Takeda Oncology Here2Assist™ | EXKIVITY® (mobocertinib)

FOR US PATIENTS ONLY

From finding financial assistance that may be right for you to understanding your disease, Takeda Oncology Here2Assist™ can provide the information you need throughout your treatment.

Takeda Oncology Here2Assist:

Works with your insurance company to help you get started on your medication
Identifies available financial assistance that may be right for you
May help you get started on treatment if there is a delay in insurance coverage determination
Connects you to additional support services and resources
Identifies specialty pharmacies to help fill and ship your prescriptions appropriately
Conducts regular follow-up calls with you
Sends you status updates and reminders via text messages*
Connects you with nurse navigators to support your product education journey

ACCESS SUPPORT: Once enrolled, Takeda Oncology Here2Assist case managers can work with you and your healthcare provider to determine your coverage options, and provide additional support throughout your treatment.

FINANCIAL ASSISTANCE: If you need assistance affording your medication, Takeda Oncology Here2Assist can help identify financial assistance programs that may be able to help you with the cost of your treatment.

HELPFUL RESOURCES: Takeda Oncology Here2Assist case managers can provide information about additional resources that may help address day-to-day concerns associated with your treatment.

Takeda Oncology Co-Pay Assistance Program

If you have commercial insurance and are concerned about your out-of-pocket costs, the Takeda Oncology Co-Pay Assistance Program^† may be able to help reduce the out-of-pocket costs associated with your medication. You could pay as little as $0 per prescription. Terms and Conditions apply.^†

To learn more about Takeda Oncology Here2Assist, call to speak with a case manager at 1-844-817-6468, Option 2, or visit www.Here2Assist.com. Let’s Talk. We’re available Monday-Friday, 8AM-8PM ET.

*Patients will need to enroll in the texting program to receive text messages.

^†By enrolling in the Takeda Oncology Co-Pay Assistance Program (the “Program”), you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions: You must be at least 18 years old, a resident of the United States or a US Territory, and have commercial (private) prescription insurance that does not cover the entire cost of the medication. The Program is not valid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicare, Medicare Advantage, Medigap, Medicaid, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who become eligible for or start using government insurance will no longer be eligible for the Program. The Program is not valid if the entire cost of your prescription is reimbursable by a private insurance plan or other private health or pharmacy benefit programs. You are responsible for reporting receipt of Program assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost, as may be required. You agree that you will not submit the cost of any portion of the product dispensed pursuant to this Program to a federal or state healthcare program (including, but not limited to, Medicare, Medicare Advantage, Medicaid, TRICARE, VA, DOD, etc.) for purposes of counting it toward your out-of-pocket expenses, and to notify Takeda Oncology Here2Assist™ if you become eligible for a federal or state healthcare program. This Program is not conditioned on any past, present, or future purchase of any Takeda product, including refills. This Program is valid for 12 months, and your co-pay card may be renewed every 12 months, subject to continued eligibility. This offer is not valid with any other program, discount, or offer involving your prescribed Takeda Oncology medication. This offer may be rescinded, revoked, or amended without notice. No reproductions. This offer is void where prohibited by law, taxed, or restricted. Limit one offer per purchase. No income requirements or membership fees. This Program is not health insurance. Cash value of 1/100 of 1¢. For questions about this offer, please contact the Takeda Oncology Co-Pay Assistance Program, a patient support service of Takeda Oncology Here2Assist, at 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about EXKIVITY?

EXKIVITY may cause serious side effects, including changes in the electrical activity of your heart called QTc prolongation and Torsades de Pointes. QTc prolongation can cause irregular heartbeats that can be life-threatening and may lead to death. Your healthcare provider will check the electrical activity of your heart with a test called an electrocardiogram (ECG) and do blood tests to check your electrolytes before starting treatment and during treatment with EXKIVITY. Tell your healthcare provider right away if you feel dizzy, lightheaded, faint or have an irregular heartbeat.

EXKIVITY may cause serious side effects, including:

Lung problems. EXKIVITY may cause severe lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you develop any new or worsening symptoms, including trouble breathing or shortness of breath, cough, chest pain, or fever.

What is EXKIVITY?

EXKIVITY is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):

that has spread to other parts of the body (metastatic) and cannot be removed by surgery, and
has a certain abnormal epidermal growth factor receptor (EGFR) gene, and
whose disease has worsened while on or after chemotherapy that contains platinum

Your healthcare provider will perform a test to make sure that EXKIVITY is right for you.

It is not known if EXKIVITY is safe and effective in children.

EXKIVITY is approved based on a medical study that measured how many people responded to treatment and for how long. There are ongoing studies to confirm its continued approval.

Heart problems, including heart failure. EXKIVITY may cause heart problems that may lead to death. Your healthcare provider should check your heart function before you start and during treatment with EXKIVITY. Tell your healthcare provider right away if you have any signs or symptoms of a heart problem, including feeling like your heart is pounding or racing, shortness of breath, chest pain, swelling of your ankles and feet, or feeling faint.
Diarrhea. Diarrhea is common during treatment with EXKIVITY and may sometimes be severe. Diarrhea can cause you to lose too much body fluid (dehydration) and kidney problems. Your healthcare provider may tell you to start drinking more fluids and electrolytes to replace body salts or start taking your antidiarrheal medicines. Tell your healthcare provider right away if you have any loose stools or have stools more often than is normal for you.

The most common side effects of EXKIVITY include diarrhea, rash, nausea, mouth sores, vomiting, decreased appetite, infection of skin around nails, tiredness, dry skin, muscle or bone pain. EXKIVITY may affect fertility in females and males, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of EXKIVITY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking EXKIVITY, tell your healthcare provider about all of your medical conditions, including if you:

have heart problems, including a condition called long QTc syndrome
have problems with your electrolytes, such as sodium, potassium, calcium or magnesium
have lung or breathing problems other than lung cancer
are pregnant or plan to become pregnant. EXKIVITY can harm your unborn baby.
Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with EXKIVITY. You should use an effective form of non-hormonal birth control during treatment and for 1 month after your last dose of EXKIVITY. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not work as well during treatment with EXKIVITY. Talk to your healthcare provider about birth control methods that might be right for you during this time. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with EXKIVITY.
Males who have female partners who are able to become pregnant:
- You should use effective birth control during treatment and for 1 week after your final dose of EXKIVITY.
are breastfeeding or plan to breastfeed. It is not known if EXKIVITY passes into your breast milk. Do not breastfeed during treatment with EXKIVITY and for 1 week after your last dose of EXKIVITY.

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you take medicines for heart problems. EXKIVITY and other medicines may affect each other causing serious side effects.

How should I take EXKIVITY?

Take EXKIVITY exactly as your healthcare provider tells you to take it.
Take your prescribed dose of EXKIVITY 1 time each day.
Take EXKIVITY with or without food.
Swallow EXKIVITY capsules whole. Do not open, chew, or dissolve the contents of the capsules.
Do not change your dose or stop taking EXKIVITY unless your healthcare provider tells you to.
Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with EXKIVITY if you develop certain side effects.
If you miss a dose of EXKIVITY, and it has been more than 6 hours, skip the dose and take your next dose at your regularly scheduled time the next day.
If you vomit a dose of EXKIVITY, do not take an extra dose. Take your next dose at your regularly scheduled time the next day.

What should I avoid while taking EXKIVITY?

Avoid eating grapefruit or drinking grapefruit juice during treatment with EXKIVITY. Grapefruit may increase the amount of EXKIVITY in your blood.

Please see Patient Information in the EXKIVITY (mobocertinib) full Prescribing Information.

Sitemap